• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus

Mary Wilson

Well-known member
Journal Pre-proof

Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus


B. Korber, W.M. Fischer, S. Gnanakaran, H. Yoon, J. Theiler, W. Abfalterer, N. Hengartner, E.E. Giorgi, T. Bhattacharya, B. Foley, K.M. Hastie, M.D. Parker, D.G. Partridge, C.M. Evans, T.M. Freeman, T.I. de Silva, C. McDanal, L.G. Perez, H. Tang, A. Moon-Walker, S.P. Whelan, C.C. LaBranche, E.O. Saphire, D.C. Montefiori, on behalf of the Sheffield COVID-19 Genomics Group

Publication History
Accepted: June 26, 2020
Received in revised form: June 10, 2020
Received: April 29, 2020

Highlights:
  • -
    A SARS-CoV-2 variant with Spike G614 has replaced D614 as the dominant pandemic form
  • -
    The consistent increase of G614 at regional levels may indicate a fitness advantage
  • -
    G614 is associated with lower RT PCR Ct’s, suggestive of higher viral loads in patients
  • -
    The G614 variant grows to higher titers as pseudotyped virions
(PDF form)
https://www.cell.com/cell/pdf/S0092...m/retrieve/pii/S0092867420308205?showall=true
 
Back
Top